Demand for Advanced Lipids’ infant formula solution soars as tenth anniversary marked

58aff1d2-cd51-499b-a39a-6898aa07b88carticleimage.jpg

04 Dec 2017 --- Demand for infant formula containing Infat SN-2 palmitate – an ingredient that mimics the fatty acid profile in human milk – has soared over the past decade and will continue to grow, according to Advanced Lipids. The company, a joint venture between Enzymotec and AAK, is celebrating its tenth anniversary this year.

Infat was clinically proven in several studies done both in Israel and China to increase fat and calcium absorption, improve bone matrix quality, improve stool consistency and have a positive effect on the development of the intestinal microbiome, Advanced Lipids reports.

Infat was also shown recently to improve babies’ well-being and the quality of life of their parents by reducing crying time and increasing sleep duration, according to the company. NutritionInsight recently reported on a study in the journal Nutrients that linked Infat to healthy bone growth in infants. (link = http://www.nutritioninsight.com/news/Advanced-Lipids-Infat-shows-strong-bone-growth-potential-for-infants.html)

Demand for infant formula rises globally
Advanced Lipids notes that at the end of 2007, when Advanced Lipids was founded, five infant formula brands incorporated Infat. Today, that figure has risen to over 150.

The global market for infant formula has almost tripled since 2006 and currently has a retail value of over US$40 billion, with China accounting for a large percentage of its retail value. Consumers in China place a premium on quality and have high awareness of the benefits of SN-2 palmitate, according to Advanced Lipids.

“In 2007 Enzymotec and AAK made the decision to join forces,” says Ronald van der Knaap, CEO of Advanced Lipids. “As a company that is looking into improving infant nutrition, we saw a great opportunity in this game-changing ingredient that supports formula manufacturers to replicate the benefits of mother’s milk as closely as possible.”

“Over the past decade we’ve been part of huge growth in the infant formula market and witnessed soaring demand for high-end products containing SN-2 palmitate,” Van der Knaap adds.

Advanced Lipids believes regulatory and demographic changes in China will lead to further growth for the formula market, particularly for premium products containing SN-2 palmitate. The recent relaxation of the country’s decades-old single child policy means that it has become a two-child policy, which the company says has sparked a “mini baby boom.” Meanwhile, the company also notes that new market regulations have put greater emphasis on quality.

“Demand for infant formula in China has soared, and the signs we get from the market indicate that growth will continue,” adds Dr. Marcus Gliwitzki, Chairman of Advanced Lipids. “However, companies are now facing a tougher market where consumers and authorities both demand high standards.”

“Over the next ten years, the focus will be on high-quality formula which contains ingredients such as Infat. Advanced Lipids will also put a strong focus on developing innovative Infat solutions in the coming years,” Dr. Gliwitzki concludes.

Related Articles

Business News

Frutarom finalizes AB-Fortis micro-encapsulation technology acquisition

13 Dec 2017 --- Frutarom has acquired AB-Fortis activities, including a patent-protected micro-encapsulation technology that enables delivery of iron with increased biological absorption. Frutarom announced the signing of an agreement with AB-Biotics S.A. of Spain for the acquisition of the activity of AB-Fortis in November.

Business News

Enzymotec and Frutarom merger gets shareholder green light

12 Dec 2017 --- The shareholders of Israeli specialty chemicals company Enzymotec Ltd. have approved by large majority the merger transaction between Frutarom and Enzymotec. The transaction was approved at Enzymotec’s General Meeting by 99.9 percent majority of shareholders present at the meeting and entitled to vote, Frutarom Industries Ltd. reports.

Nutrition & Health News

Energetic growth: Energy boosters add pep to the nutritional space’s step

11 Dec 2017 --- Busy schedules can cause consumers to go through an “energy crisis” – prompting their desire to reach for products that might offer some support to their energy levels. Energy boosters are certainly showing signs of growth in all regions tracked by Innova Market Insights. A CAGR in supplement launches of +208.8 percent in South America from 2012 to 2016 is particularly noteworthy, while Europe is top of the pile worldwide with 28.8 percent of its supplement launches having an energy claim in 2016 and its CAGR amounting to a strong +86.7 percent.

Business News

Nestle acquires Atrium for US$2.3 billion, extends consumer healthcare portfolio

06 Dec 2017 --- Nestle has agreed to acquire Canadian nutritional health products manufacturer Atrium Innovations from a group of investors led by Permira Funds for US$2.3 billion in cash. Nestle notes that the move for the company, whose 2017 sales are expected to reach almost US$700 million, supports Nestle’s pursuit of growth opportunities in consumer healthcare to complement the company's focus on its high-growth food and beverage categories.

Food Ingredients News

Ingredia presents milk proteins in shelf-stable and high protein snacking concepts

05 Dec 2017 --- Consumers around the world are increasingly interested in achieving wellness through a healthy diet. To meet this mainstream trend, food and dairy producers continue to reduce fat content while increasing the protein amount in their products. At this year's FiE, Ingredia were presenting healthy, convenient and indulgent products with their PROMILK 600 A and PROMILK SH 20 dairy ingredients.

More Articles
URL : http://www.nutritioninsight.com:80/news/demand-for-advanced-lipids-infant-formula-solution-soars-as-tenth-anniversary-marked.html